Hughes Hubbard & Reed LLP represented Cyclerion Therapeutics in the deal. Cyclerion Therapeutics (NASDAQ: CYCN) announced the company’s sale of the rights to two drugs used...
Cyclerion Therapeutics’ Sale of Medicine to Treat Mitochondrial Encephalopathy
Kensington Capital Acquisition Corp. IV’s Merger With Amprius Technologies
Hughes Hubbard & Reed represented Kensington Capital Acquisition Corp. IV in the transaction while Wilson Sonsini represented Amprius Technologies. Kensington Capital Acquisition Corp. IV executed its business...
Cantor Fitzgerald SPAC’s Business Combination with Rumble
Hughes Hubbard and Bennett Jones represented CF Acquisition Corp. VI in the transaction. Willkie Farr & Gallagher and DLA Piper Canada represented Rumble. CF Acquisition Corp. VI,...